Telcon RF Pharmaceutical prepays KRW 2.81 billion of convertible bond debt ahead of maturity

PUBT · 2d ago
Telcon RF Pharmaceutical prepays KRW 2.81 billion of convertible bond debt ahead of maturity
  • Telcon RF Pharmaceutical decided to repurchase KRW 2.81 billion of its 23rd private convertible bonds before maturity.
  • Repurchase covers KRW 2.7 billion in face value, via off-market purchase under an early redemption agreement.
  • Payment set for Sept. 29, 2026, funded from internal resources; bonds slated for cancellation following acquisition.
  • The 23rd convertible bonds were issued April 22, 2025; maturity is April 22, 2028.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telcon RF Pharmaceutical Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260929000286), on September 29, 2026, and is solely responsible for the information contained therein.